For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220628:nRSb5350Qa&default-theme=true
RNS Number : 5350Q ConvaTec Group PLC 28 June 2022
ConvaTec Group Plc
BLOCK LISTING SIX MONTHLY RETURN
Date: 28 June 2022
Name of applicant: ConvaTec Group Plc
Name of scheme: ConvaTec Group Plc Long Term Incentive Plan
Period of return: From: 21 December 2021 To: 20 June 2022
Balance of unallotted securities under scheme(s) from previous return: 9,850,000
Plus: The amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during period 9,850,000
(see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 0
Name of applicant: ConvaTec Group Plc
Name of scheme: ConvaTec Group Plc US Employee Stock Purchase Plan
Period of return: From: 21 December 2021 To: 20 June 2022
Balance of unallotted securities under scheme(s) from previous return: 290,000
Plus: The amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during period 290,000
(see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 0
Name of applicant: ConvaTec Group Plc
Name of scheme: ConvaTec Group Plc Share Plan
Period of return: From: 21 December 2021 To: 20 June 2022
Balance of unallotted securities under scheme(s) from previous return: 3,000,000
Plus: The amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during period 3,000,000
(see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 0
Name of applicant: ConvaTec Group Plc
Name of scheme: ConvaTec Group Plc Deferred Bonus Plan
Period of return: From: 21 December 2021 To: 20 June 2022
Balance of unallotted securities under scheme(s) from previous return: 430,000
Plus: The amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during period 430,000
(see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 0
Name of applicant: ConvaTec Group Plc
Name of scheme: ConvaTec Group Plc UK SAYE
Period of return: From: 21 December 2021 To: 20 June 2022
Balance of unallotted securities under scheme(s) from previous return: 1,830,000
Plus: The amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during period 1,830,000
(see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 0
Name of applicant: ConvaTec Group Plc
Name of scheme: ConvaTec Group Plc Global SAYE Sub-Plan
Period of return: From: 21 December 2021 To: 20 June 2022
Balance of unallotted securities under scheme(s) from previous return: 4,600,000
Plus: The amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during period 4,600,000
(see LR3.5.7G):
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 0
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations,
ConvaTec
+44 (0)782 644 7807
ir@convatec.com (mailto:ir@convatec.com)
Media
Buchanan: Charles Ryland / Chris Lane
+44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on
solutions for the management of chronic conditions, with leading market
positions in advanced wound care, ostomy care, continence and critical care,
and infusion care. Our products provide a range of clinical and economic
benefits including infection prevention, protection of at-risk skin, improved
patient outcomes and reduced total cost of care. To learn more about ConvaTec,
please visit www.convatecgroup.com (http://www.convatecgroup.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BLRBLGDLXDDDGDI